fbpx

Health Care

Novartis to initiate clinical study of Jakavi in severe COVID-19 patients

“The potential that Jakavi could lead to faster recovery times for COVID-19 patients with fewer requiring intensive care and mechanical ventilation is encouraging and absolutely merits further investigation," said Head of Global Drug Development and Chief Medical Officer John Tsai. "We now are moving rapidly to finalize the study plan and then to enroll eligible patients, as well as put in place a process to provide access for patients unable to participate in the trial."

Read More »